World Malaria Day and World Immunization Week 2015

Ashley Birkett, director of MVI, highlights efforts to prevent malaria parasite transmission and discusses the value of new tools, such as malaria vaccines.

Read more »

 

Malaria vaccine candidate has demonstrated efficacy over 3-4 years of follow-up

Final results from Phase III trial of RTS,S malaria vaccine candidate, including the impact of a booster dose, published today in The Lancet.

Read the press release »

Ashley Birkett

 

 

World Immunization Week banner

Partnering with us

PuzzleWe are pursuing a range of vaccine development approaches with an expanding circle of industry, academic, and government partners.

Our portfolio

MVI portfolioWe maintain a diverse portfolio of projects, including preclinical feasibility studies, translational projects, and one advanced clinical project.

View the portfolio »Subscription button

What we do and how we do it

MVI overview imageWe identify potentially promising malaria vaccine approaches and systematically move them through the development process. At the same time, we work to catalyze access to a successful malaria vaccine in the countries that need it most.

Read more »


WMD

 

News and announcementsWalking together: Steve Davis reflects on 15 years of Gavi partnership

This week on Gavi’s blog, Steve Davis, president and CEO of PATH, provided insight on what it takes to develop and strengthen a global community of scientists, policymakers, advocates, regulators, medical workers, and caregivers to continue our good work.

 

Malaria vaccine gets a shot in the arm

MVI announces $156 million grant from Bill & Melinda Gates Foundation to support essential vaccine role in strategy to eradicate malaria.

 

Japan's Global Health Innovative Technology Fund announces award to MVI

MVI welcomes announcement by Japan’s Global Health Innovative Technology Fund of a grant to MVI and its partner Ehime University to fast-track the development of a novel malaria vaccine candidate. The new vaccine approach is targeted at blocking malaria parasite transmission between humans and mosquitoes.


Events and Conferences

Global Conference on Vaccines
April 13–15, 2015